KRNY Stock Analysis: Kearny Financial | NASDAQ
Banks - Regional | NASDAQ, USA | Market Cap: 574m USD | 12M Return: 44.9% | US48716P1084 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 4.23M
EPS Trend: 21.7%
Qual. Beats: 0
Rev. Trend: 82.6%
Qual. Beats: 0
Warnings
Tailwinds
No distinct edge detected
Seasonality 11.9 years of data, until 10/2026
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, ≥40 worth a closer look and ≥60 is strong.
Kearny Financial Corp. (KRNY) operates as the holding company for Kearny Bank, a U.S. community bank offering a full range of consumer and commercial banking products. Its deposit offerings include interest-bearing and non-interest-bearing checking accounts, money market deposit accounts, savings accounts, IRAs, and certificates of deposit. The company is classified under the GICS Regional Banks sub-industry, reflecting its traditional deposit-funded, relationship-based lending model.
The banks loan portfolio spans multifamily and nonresidential commercial real estate mortgages, commercial and industrial loans, construction loans, one-to-four-family residential mortgages, home equity loans, personal loans, and consumer loans. It also provides overdraft lines of credit and participates in investment activities, giving it multiple interest-earning asset channels beyond core lending.
Beyond core banking, Kearny offers treasury management, commercial deposit products, corporate banking, wealth management, and insurance brokerage services. It serves consumers, small and middle-market businesses, professionals, nonprofit organizations, and government entities through branch locations and digital banking channels. Founded in 1884 and headquartered in Fairfield, New Jersey, the company has operated as a community-oriented institution for more than 140 years.
- Net interest margin compresses as Fed cuts rates
- Multifamily CRE loan portfolio faces rising credit risk
- Commercial banking expansion diversifies revenue mix
| Net Income: 36.8m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.01 > 0.02 and ΔFCF/TA 0.27 > 1.0 |
| NWC/Revenue: -1.37k% < 20% (prev -1.35k%; Δ -17.49% < -1%) |
| CFO/TA 0.01 > 3% & CFO 44.1m > Net Income 36.8m |
| Net Debt (-17.0m) to EBITDA (52.5m): -0.32 < 3 |
| Current Ratio: 0.20 > 1.5 & < 3 |
| Outstanding Shares: last quarter (63.6m) vs 12m ago 0.97% < -2% |
| Gross Margin: 50.90% > 18% (prev 46.02%; Δ 4.88% > 0.5%) |
| Asset Turnover: 4.51% > 50% (prev 4.50%; Δ 0.02% > 0%) |
| Interest Coverage Ratio: 0.29 > 6 (EBIT TTM 48.1m / Interest Expense TTM 168.4m) |
| A: -0.61 (Total Current Assets 1.19b - Total Current Liabilities 5.96b) / Total Assets 7.78b |
| B: 0.05 (Retained Earnings 353.1m / Total Assets 7.78b) |
| C: 0.01 (EBIT TTM 48.1m / Avg Total Assets 7.71b) |
| D: 0.11 (Book Value of Equity 755.9m / Total Liabilities 7.02b) |
| Altman-Z'' = -3.72 = D |
| DSRI: 1.05 (Receivables 31.3m/29.5m, Revenue 348.2m/344.0m) |
| GMI: 0.90 (GM 46.02% / 50.90%) |
| AQI: 1.00 (AQ_t 0.84 / AQ_t-1 0.84) |
| SGI: 1.01 (Revenue 348.2m / 344.0m) |
| TATA: -0.00 (NI 36.8m - CFO 44.1m) / TA 7.78b) |
| Beneish M = -3.06 (Cap -4..+1) = AA |
As of November 20, 2026, the stock is trading at USD 8.80 with a total of 534,440 shares traded. Over the past week, the price has changed by -3.83%, over one month by +0.40%, over three months by -7.52% and over the past year by +44.86%.
Current recommended Stop Loss: 8.50 (which is 3.4% or 1.4 ATR below the current price).
Kearny Financial has received a consensus analysts rating of 3.67. Therefore, it is recommended to hold KRNY.
- StrongBuy: 0
- Buy: 2
- Hold: 1
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 10.5 | 19.3% |
P/E Trailing = 15.6552
P/E Forward = 11.4943
P/S = 3.2391
P/B = 0.7653
P/EG = 15.99
Revenue TTM = 348.2m USD
EBIT TTM = 48.1m USD
EBITDA TTM = 52.5m USD
Long Term Debt = 200.0m USD (from longTermDebt, last quarter)
Short Term Debt = 110.0m USD (from shortTermDebt, last quarter)
Debt = 1.14b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -17.0m USD (calculated: Debt 1.14b - CCE 1.15b)
Enterprise Value = 557.0m USD (574.1m + Debt 1.14b - CCE 1.15b)
Interest Coverage Ratio = 0.29 (Ebit TTM 48.1m / Interest Expense TTM 168.4m)
EV/FCF = 13.15x (Enterprise Value 557.0m / FCF TTM 42.4m)
FCF Yield = 7.60% (FCF TTM 42.4m / Enterprise Value 557.0m)
FCF Margin = 12.17% (FCF TTM 42.4m / Revenue TTM 348.2m)
Net Margin = 10.57% (Net Income TTM 36.8m / Revenue TTM 348.2m)
Gross Margin = 50.90% ((Revenue TTM 348.2m - Cost of Revenue TTM 171.0m) / Revenue TTM)
Gross Margin QoQ = 49.71% (prev 51.39%)
Tobins Q-Ratio = 0.07 (Enterprise Value 557.0m / Total Assets 7.78b)
Interest Expense / Debt = 14.83% (Interest Expense 168.4m / Debt 1.14b)
Taxrate = 23.49% (11.3m / 48.1m)
NOPAT = 36.8m (EBIT 48.1m * (1 - 23.49%))
Current Ratio = 0.20 (Total Current Assets 1.19b / Total Current Liabilities 5.96b)
Debt / Equity = 1.50 (Debt 1.14b / totalStockholderEquity, last quarter 755.9m)
Debt / EBITDA = -0.32 (Net Debt -17.0m / EBITDA 52.5m)
Debt / FCF = -0.40 (Net Debt -17.0m / FCF TTM 42.4m)
Total Stockholder Equity = 760.8m (last 4 quarters mean from totalStockholderEquity)
RoA = 0.48% (Net Income 36.8m / Total Assets 7.78b)
RoE = 4.84% (Net Income TTM 36.8m / Total Stockholder Equity 760.8m)
RoCE = 5.01% (EBIT 48.1m / Capital Employed (Equity 760.8m + L.T.Debt 200.0m))
RoIC = 1.93% (NOPAT 36.8m / Invested Capital 1.91b)
WACC = 10.02% (E(574.1m)/V(1.71b) * Re(7.39%) + D(1.14b)/V(1.71b) * Rd(14.83%) * (1-Tc(0.23)))
Discount Rate = 7.39% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 98.74 | Cagr: 0.93%
[DCF] Terminal Value 72.76% ; FCFF base≈34.0m ; Y1≈38.9m ; Y5≈57.3m
[DCF] Fair Price = 10.80 (EV 665.7m - Net Debt -17.0m = Equity 682.7m / Shares 63.2m; r=10.02% [WACC]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 21.73 | EPS CAGR: 4.30% | SUE: -0.84 | # QB: 0
Revenue Correlation: 82.58 | Revenue CAGR: 3.37% | SUE: 0.73 | # QB: 0
EPS current Quarter (2026-12-31): EPS=0.18 | Chg30d=-5.36% | Revisions=-40% | Analysts=3
EPS next Quarter (2027-03-31): EPS=0.20 | Chg30d=-4.84% | Revisions=-50% | Analysts=3
EPS current Year (2027-06-30): EPS=0.75 | Chg30d=-4.25% | Revisions=-50% | GrowthEPS=+27.7% | GrowthRev=+9.9%
EPS next Year (2028-06-30): EPS=0.95 | Chg30d=-4.52% | Revisions=-40% | GrowthEPS=+26.1% | GrowthRev=+11.2%
[Analyst] Revisions Ratio: -77% (up=0, down=10)